• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

190.3400 USD 1.2600 0.67%

As of 20:04:02 ET on 12/19/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 188.1700 High - Low: 191.7200 - 186.1900 Primary Exchange: NYSE Arca
Volume: 746,432 52-Week Range: 115.3117 - 191.7200 Beta vs SPSIBITR: 0.9993

ETF Chart for XBI

No chart data available.
  • XBI:US 190.3400
  • 1D
  • 1M
  • 1Y
189.0800
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-12-19) 190.6604
Assets (M) (on 2014-12-19) 1,468.0850
Shares out (M) 7.70
Market Cap (M) 1,465.62
% Premium -0.17
Average 52-Week % Premium -0.0102
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.4910
Dividend Yield (ttm) 1.05%

Performance for XBI

1-Month +12.28% 1-Year +54.49%
3-Month +20.57% 3-Year +45.64%
Year To Date +48.00% 5-Year +30.33%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 12/19/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 356,362 42,628,022 2.897%
Bluebird Bio Inc 427,077 39,291,084 2.670%
Receptos Inc 264,137 35,291,345 2.398%
PTC Therapeutics Inc 481,674 27,306,099 1.856%
AMAG Pharmaceuticals Inc 617,181 27,260,885 1.853%
Incyte Corp 323,536 24,866,977 1.690%
Isis Pharmaceuticals Inc 381,717 24,845,960 1.689%
Merrimack Pharmaceuticals Inc 2,167,896 23,933,572 1.627%
Neurocrine Biosciences Inc 976,442 23,913,065 1.625%
Cubist Pharmaceuticals Inc 234,698 23,157,652 1.574%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil